Enanta Pharmaceuticals Inc 10-K for FY2022
Enanta Pharmaceuticals Inc (ENTA)
10-K
2022-11-23
For: 2022-09-30
View Original
Added on
April 06, 2026
About this 10-K
Enanta Pharmaceuticals Inc filed this 10-K on November 23, 2022, covering the fiscal year ended September 30, 2022 (FY2022).
Headline figures
Fiscal year ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $86.16M
- down 11.2% from $97.07M a year earlier
- Net loss
- $121.76M
- compared with a net loss of $79M a year earlier
- Diluted EPS
- -$5.91
- compared with -$3.92 a year earlier